Association of Clinical Research Organizations (ACRO) - Comment

Document ID: FDA-2012-N-0170-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: April 16 2012, at 12:00 AM Eastern Daylight Time
Date Posted: April 16 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: March 7 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: May 31 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80ff18f6
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

ACRO_FDA_Testimony_4.16.12

Title:
ACRO_FDA_Testimony_4.16.12

View Attachment: View as format msw8 View as format pdf

Related Comments

    View All
Total: 30
PSPC Alliance - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0002

May 31,2012 11:59 PM ET
John Anthony Laczin - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0003

May 31,2012 11:59 PM ET
Association of Clinical Research Organizations (ACRO) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0004

May 31,2012 11:59 PM ET
Regulatory Education and Action for Patients (REAP) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0005

May 31,2012 11:59 PM ET
National Patient Advocate Foundation (NPAF) - Comment
Public Submission    Posted: 04/16/2012     ID: FDA-2012-N-0170-0006

May 31,2012 11:59 PM ET